Author: Lichao Fan; Chang Liu; Na Li; Huan Liu; Ye Gu; Yongyu Liu; Yu Chen
Title: Medical treatment of 55 patients with COVID-19 from seven cities in northeast China who fully recovered: a single-center, retrospective, observational study Document date: 2020_3_30
ID: hc0za6fh_5
Snippet: We performed a single-center, retrospective, and observational study at Shenyang Sixth People's Hospital (Shenyang, Liaoning, China), a government-designated centralized medical facility for the treatment of patients with COVID-19 in Liaoning Province. All patients were from hospitals that received patients for initial COVID-19 treatment in seven cities in Liaoning Province, including Shenyang Chest Hospital. According to the Interim Guidelines i.....
Document: We performed a single-center, retrospective, and observational study at Shenyang Sixth People's Hospital (Shenyang, Liaoning, China), a government-designated centralized medical facility for the treatment of patients with COVID-19 in Liaoning Province. All patients were from hospitals that received patients for initial COVID-19 treatment in seven cities in Liaoning Province, including Shenyang Chest Hospital. According to the Interim Guidelines issued by the World Health Organization (WHO) on January 12, 2020, 3 patient throat swabs and sputum samples were collected and subjected to a nucleic acid (RNA) test for COVID-19. We included all 55 consecutive patients with COVID-19 who were treated between January 20 and March 15, 2020; none were excluded. Patients were considered the 'mild' group (mild/moderate), whereas those were considered the 'severe' group (severe/critical); these classifications were according to the criteria stated in the COVID-19 Diagnosis and Treatment Plan issued by the National Health Commission of the People's Republic of China. 2 The study was reviewed and approved by the Ethics Committee of Shenyang Chest Hospital (approval number: KYXM-2020-001-01) and was also documented by the Ethics Committee of the Shenyang Sixth People's Hospital. Written informed consent forms were waived owing to the rapid development of the infectious COVID-19 disease.
Search related documents:
Co phrase search for related documents- approval number and nucleic acid: 1, 2
- approval number and patient treatment: 1, 2
- approval number and single center: 1, 2
- consecutive patient and nucleic acid: 1, 2, 3, 4, 5
- consecutive patient and patient receive: 1
- consecutive patient and patient treatment: 1, 2, 3, 4, 5, 6, 7, 8
- consecutive patient and single center: 1, 2, 3, 4, 5
- consecutive patient and throat swab: 1
- government designate and infectious disease: 1
- infectious disease and medical facility: 1, 2, 3, 4, 5, 6
- infectious disease and mild moderate group: 1, 2, 3, 4, 5
- infectious disease and nucleic acid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- infectious disease and observational retrospective single center: 1, 2
- infectious disease and observational retrospective single center study: 1, 2
- infectious disease and patient receive: 1, 2
- infectious disease and patient treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- infectious disease and rapid development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47
- infectious disease and seven city: 1
- infectious disease and severe critical group: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date